June 2/Salt Lake City/Business Wire -- Schiff Nutrition International Inc., through its subsidiary Schiff Nutrition Group Inc., purchased certain assets and assumed certain liabilities of Ganeden Biotech Inc. for $40 million in cash utilizing its existing revolving credit facility. Schiff now owns (1) the worldwide exclusive rights to use the probiotic technology GanedenBC30® (BC30, Bacillus coagulans GBI-30, 6086) in the over-the-counter and dietary supplement space and (2) the brands Sustenex® and Digestive Advantage® under which BC30 is currently sold. Ganeden and Schiff also intend to collaborate on extending the use of probiotic technologies into new areas of human health.
The probiotics category is growing over 20% on an annualized basis, according to Nutrition Business Journal. BC30 has over 95 U.S. and foreign patents and patent applications.